We queried all breast cancer datasets housed in the OncomineTM Research Platform (132 datasets, 14,277 samples) [37,38] to determine if BDP1 copy number or mRNA expression is altered in breast cancer and if BDP1 alterations correlated with clinical outcomes in breast cancer. This evidence concerns the gene BDP1 and breast carcinoma.